Becton, Dickinson and Company Stock price
Equities
BDX
US0758871091
Medical Equipment, Supplies & Distribution
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
237.7 USD | +0.43% | -0.74% | -2.51% |
Financials (USD)
Sales 2024 * | 20.31B | Sales 2025 * | 21.5B | Capitalization | 68.39B |
---|---|---|---|---|---|
Net income 2024 * | 2.11B | Net income 2025 * | 2.76B | EV / Sales 2024 * | 4 x |
Net Debt 2024 * | 12.83B | Net Debt 2025 * | 10.25B | EV / Sales 2025 * | 3.66 x |
P/E ratio 2024 * |
33.3
x | P/E ratio 2025 * |
26.3
x | Employees | 73,000 |
Yield 2024 * |
1.57% | Yield 2025 * |
1.6% | Free-Float | 77.85% |
Latest transcript on Becton, Dickinson and Company
1 day | +0.43% | ||
1 week | -0.91% | ||
Current month | +0.92% | ||
1 month | -1.26% | ||
3 months | +0.30% | ||
6 months | -9.87% | ||
Current year | -2.51% |
Managers | Title | Age | Since |
---|---|---|---|
Thomas Polen
CEO | Chief Executive Officer | 50 | 08-12-31 |
Director of Finance/CFO | 52 | 21-09-05 | |
Chief Tech/Sci/R&D Officer | 48 | 18-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bertram Scott
BRD | Director/Board Member | 73 | 02-09-23 |
Catherine Burzik
BRD | Director/Board Member | 73 | 13-01-28 |
Director/Board Member | 69 | 10-07-25 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
15.40% | 227 M€ | +9.20% | - | |
2.47% | 6 M€ | +16.84% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-03-18 | 237.7 | +0.43% | 1,141,814 |
24-03-15 | 236.7 | -0.19% | 2,686,011 |
24-03-14 | 237.2 | -0.68% | 1,121,634 |
24-03-13 | 238.8 | +0.41% | 961,420 |
24-03-12 | 237.8 | -0.70% | 1,219,859 |
Delayed Quote Nyse, March 18, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.51% | 68.39B | |
+2.15% | 200B | |
+1.55% | 111B | |
+8.57% | 50.29B | |
+16.52% | 47.47B | |
+10.33% | 45.04B | |
+10.61% | 28.87B | |
+7.68% | 28.45B | |
+12.38% | 28.38B | |
+25.66% | 28.32B |